MRA and PFR work together for development of Polish Biotechnology
The Polish Development Fund Group (PFR) and the Medical Research Agency have signed an agreement on cooperation for development of Polish biotechnology and medical research sector in Poland.
The agreement includes cooperation for developing MRA's strategy concerning financing of projects and also MRA's qualitative support in the scope of business financing and development when creating an operating model of clinical research development in health care facilities.
"Creation of complimentary support programmes, that would not duplicate their offers, is our common objective. MRA would like to announce the first competitions in the area of non-commercial research late this year. We will design new tools that are supposed to fill the gaps in the system of financing" - stressed Radosław Sierpiński, MD, PhD, acting President of the Medical Research Agency.
The Medical Research Agency, as a part of the Business Accelerators Programme of the PFR, will also join the process of implementation of accelerators in the area of health care. Both organisations will cooperate for development of clinical research sector in Poland, especially in the scope of "Patient in clinical research" project communication.
"Biotechnology sector is a key sector for development of Polish economy, defined in the Strategy for Responsible Development. The Polish Development Fund Group, through Life Science PFR and PFR Ventures funds, is an active investor on that market. I am glad that, as PFR, we may support the Medical Research Agency in its ambitious plans of development that in the near future may result in creation of our own Polish medicines and innovative technologies" - said Paweł Borys, chairman of the Board of the Polish Development Fund.
PFR and PFR Group take active part in financing biotechnology development in Poland. Through PFR Ventures funds or PFR Life Science fund, the Fund is engaged in the activities of a number of companies from the medical industry, at various stages of development. MRA will use this experience when creating complementary financing tools. The project "Patient in clinical research" implemented in cooperation with patient organisation, the Ministry of Health and the Polish Development Fund will be passed into the custody of the Medical Research Agency.